Mitral Valve Repair Surgery: Is It an Option for My Dog?

Every owner of a dog with mitral valve disease eventually has the same thought. The tablets are wonderful, and pimobendan in particular can buy a great deal of good time (Boswood et al., 2016), but they manage a leaking valve. They do not mend it. So a fair question follows: if the problem is a worn-out valve, can a surgeon not simply fix the valve?

The honest answer is that, for a small but growing number of dogs, yes, they now can. Mitral valve disease is the one common canine heart condition where the underlying fault is mechanical, a valve that no longer seals, and mechanical faults can in principle be repaired. This article gives you the genuine picture of where surgical repair stands today: what it involves, who can realistically have it, what it costs, and how to go about exploring it without either getting your hopes up unfairly or dismissing a real option too quickly. It assumes you already know the basics from the anchor guide to mitral valve disease and understand the ACVIM stages, so it will not re-tread either.

Why repair, not just manage: fixing the cause

Standard treatment for mitral valve disease is, at heart, a holding action. Pimobendan helps the heart pump and eases the load on it. A diuretic such as furosemide clears the fluid that backs up once the disease reaches the heart-failure stage. These drugs are genuinely effective and have transformed how long and how well dogs live with this condition, and for the overwhelming majority of dogs they remain the right and the only realistic plan. The medical regimen in detail belongs to the heart failure medication toolkit, so I will not duplicate it here.

But medication does not change the valve itself. Over months and years it continues to thicken and leak, the heart continues to enlarge to compensate, and eventually the compensation runs out. Surgical repair is different in kind, not just in degree. Instead of helping the heart cope with a faulty valve, it sets out to correct the valve so the leak itself is reduced or abolished. If that works, the backward pressure that drives the whole disease falls away, the enlarged heart can begin to recover some of its size and function, and a dog who would have needed lifelong and escalating medication may need much less, or in the best cases very little. That is the prize, and it is a real one. The rest of this article is about how attainable it is.

Open repair on bypass, and the catheter-based approach

There are two broad ways to mend a mitral valve, and they are very different undertakings.

The established, gold-standard technique is open surgical repair on cardiopulmonary bypass. This is open-heart surgery in the fullest sense. The dog is placed on a heart-lung bypass machine, which takes over the work of the heart and lungs so the surgeon can stop the heart, open it, and work directly on the valve. The repair itself usually combines two steps: replacing the stretched and ruptured cords that should anchor the valve leaflets (these are rebuilt with artificial cords, typically of expanded PTFE, the same material used in human valve surgery), and tightening the dilated valve ring with a ring or stitch so the leaflets meet again, a step called annuloplasty. Done well, this can dramatically reduce or even abolish the leak. The technique has been refined over many years, with much of the pioneering high-volume work carried out in Japan and subsequently at a small number of centres elsewhere, and reported survival to discharge at experienced centres is high. It is, however, one of the most demanding operations in all of veterinary medicine, and depends utterly on the skill of the surgical and bypass team around the dog.

The newer, less invasive route is transcatheter mitral valve repair. Rather than opening the chest and stopping the heart, the surgeon works through a small incision and threads a device to the valve under image guidance, on a beating heart. The best known of these systems clips the two valve leaflets together at their midpoint, so that instead of one large leak there are two smaller channels and the valve seals far better. This edge-to-edge clip approach is well established in human cardiology and has been adapted for dogs, with the first canine procedures performed in recent years and a growing, though still early, body of experience. The appeal is obvious: no bypass machine, a shorter and less traumatic procedure, and potentially a wider pool of dogs who could tolerate it. The caveat is equally important: it is genuinely new in dogs, long-term outcome data are still being gathered, and it does not suit every type of valve. Both routes are evolving quickly, which is exactly why anything you read about availability, including this article, should be treated as a snapshot and confirmed with a specialist at the time you are asking.

Where it is available, and what it costs

This is where realism has to come in, because availability is the single biggest limiting factor.

Mitral valve surgery is performed at only a handful of centres worldwide. It requires not just a skilled cardiac surgeon but an entire team: anaesthetists experienced in bypass, perfusionists to run the heart-lung machine, intensive aftercare, and the equipment to match. That combination is rare and cannot be assembled quickly. In the United Kingdom, open repair on bypass has been offered at a very small number of referral centres, and the picture changes as programmes start, pause, or develop, so the only reliable way to know who is currently operating, and on which dogs, is to ask a cardiologist directly. Demand at the established centres also tends to outstrip capacity, so waiting lists are a genuine consideration, and a dog's disease does not pause while it waits.

Cost is substantial and should be discussed frankly and early. Open repair is among the most expensive procedures in veterinary medicine, typically running into many thousands of pounds once the surgery, the bypass, the hospital stay and the intensive aftercare are accounted for, and figures of a similar order have been quoted at overseas centres. Transcatheter repair, being less resource-heavy, may sit lower, but it is still a major expense. Pet insurance may cover part of the cost depending on the policy and whether the heart condition was already known when cover began, so it is well worth checking your wording in detail before assuming either way. None of this should put you off asking the question. It simply means the financial conversation is part of the medical one, not an afterthought.

Which dogs are realistic candidates, and the honest risks

Surgery is not a better version of the tablets for every dog. It is a different path that suits a particular kind of patient, and being clear-eyed about candidacy is kinder than false hope.

In broad terms, the dogs most likely to be considered are those whose disease has progressed enough that surgery offers a real advantage over medication, typically dogs with significant enlargement or early or established heart failure, yet who are otherwise well enough to come through a major operation. Surgeons generally look for a dog who is stable on medication rather than in the middle of a crisis, without other serious illness, and of a body size the team can technically work with: the very smallest dogs and the heart's small structures make open repair more challenging, though techniques continue to widen the range. A dog whose heart disease is still very mild may be advised to wait, because the risks of major surgery are not justified when medication is doing the job well, while a dog who is extremely advanced or unstable may have passed the point where surgery can be done safely. There is, in other words, a window, and part of the specialist's job is judging whether your dog is in it.

The risks have to be stated plainly. This is open or near-open heart surgery, and the possible complications are serious: bleeding, abnormal heart rhythms, problems coming off bypass, clot formation, neurological complications, kidney injury, and, despite everything, death around the time of surgery. At the most experienced, highest-volume centres the chance of leaving hospital alive is reported to be good, but those results reflect exceptional teams and carefully chosen patients, and outcomes at newer or lower-volume programmes may not match them. A frank, numbers-based conversation about that specific centre's results, in dogs like yours, is essential. The most useful question you can ask is not "does this surgery work?" in the abstract, but "what happens to dogs of my dog's size and stage, operated on by your team?"

How to explore it: the referral conversation

If, having read all that, you still want to find out whether surgery could be right for your dog, the path is straightforward even though the surgery is not. The starting point is a conversation with a board-certified veterinary cardiologist, not the surgeon directly. The cardiologist will assess your dog's stage, do a detailed echocardiogram, and give you a grounded view of whether referral for a surgical opinion is sensible, premature, or no longer advisable. Working with a cardiologist walks through how that referral works and how to get the most from the appointment, so do read it before you go. Your own vet can make that referral; you do not have to navigate it alone.

Bring your questions written down, and bring your dog's history, ideally including any previous scans and the trend in their resting breathing rate. If you have been logging it with the breathing rate tracker, that record is genuinely useful evidence of how stable your dog is, and stability is part of what determines candidacy.

A final word of perspective. Surgery is a remarkable and genuinely improving option, and for the right dog it can be life-changing. But it is not yet the answer for most dogs with this disease, and choosing well-managed medical treatment is not a lesser choice or a failure to do enough. The great majority of dogs live well, for a long time, on tablets alone. If your real worry is how much time the medical path can buy, that question deserves an honest answer of its own, and you will find it in prognosis and what the numbers really mean.